<SEC-DOCUMENT>0001188112-11-001977.txt : 20110721
<SEC-HEADER>0001188112-11-001977.hdr.sgml : 20110721
<ACCEPTANCE-DATETIME>20110721164321
ACCESSION NUMBER:		0001188112-11-001977
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20110718
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110721
DATE AS OF CHANGE:		20110721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	002-90539
		FILM NUMBER:		11980219

	BUSINESS ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631 444 6861

	MAIL ADDRESS:	
		STREET 1:		25 HEALTH SCIENCES DRIVE
		STREET 2:		SUITE 113
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t71167_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>t71167_8k.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<br>
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">______________________</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">PURSUANT TO SECTION 13 OR 15(d) OF THE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">____________________</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of report (Date of earliest event reported): July 18, 2011</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact Name of Registrant as Specified in Charter)</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(State or Other Jurisdiction</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">of Incorporation)</font></div>
</td>
<td valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">002-90539</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="27%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">59-2262718</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(IRS Employer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">25 Health Sciences Drive, Suite 215</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stony Brook, New York 11790</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of Principal Executive Offices) (Zip Code)</font><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">631-444- 8090</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Not Applicable</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Former Name or Former Address, if Changed Since Last Report)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">&#168;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">&#168;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">&#168;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">&#168;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 1.01&#160;&#160;Entry into a Material Definitive Agreement</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On July 18, 2011, Applied DNA Sciences, Inc. (the &#8220;Company&#8221;) entered into a Joint Development Agreement, dated as of June 30, 2011 (the &#8220;Agreement&#8221;) with C.F. Martin &amp; Co., Inc., a designer and manufacturer of acoustic guitars, strings for acoustic guitars, and related guitar components and accessories (&#8220;Martin&#8221;).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Under the terms of the Agreement, Martin and the Company will jointly develop, create and apply new techniques and know-how for labeling and authenticating guitars, guitar strings and related guitar components and accessories using DNA security markers created by the Company.&#160;&#160;Under the Agreement, each party shall bear and be responsible for its own expenses and costs of the development and creation of the techniques and know-how.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Subject to certain exceptions for the Company, the Agreement provides for a period of exclusivity (&#8220;Period of Exclusivity&#8221;) of six (6) months beginning on June 30, 2011 whereby Martin and the Company agree not to sell, offer for sale, enter into any agreement with any third party for the future sale of, advertise, or market, anywhere in the world, any jointly developed technique for labeling guitars, guitar strings, and related guitar components and accessories with DNA security markers.&#160;&#160;The Agreement also provides that Martin shall purchase DNA security markers exclusively from the Company during the longer of the term of the Agreement or the Period of Exclusivity.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The term of the Agreement will continue until the parties agree that the development and creation of techniques or know-how for labeling guitars or guitar strings with DNA security markers is complete, unless either party terminates the Agreement by giving at least sixty (60) days written notice to the other party.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">A copy of the press release issued by the Company on July 19, 2011 relating to the Agreement is attached as Exhibit 99.1 and is incorporated herein by reference.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01 Financial Statements and Exhibits</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>
</td>
<td style="WIDTH: 72pt">
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Exhibit 99.1</font></div>
</td>
<td>
<div align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Press Release issued by Applied DNA Sciences, Inc. on July 19, 2011.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">- 2 -</font></div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURE</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="41%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Applied DNA Sciences, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="41%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Registrant)</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="top" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="41%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: <font style="DISPLAY: inline; TEXT-DECORATION: underline">/s/ James A. Hayward&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="41%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">James A. Hayward</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td align="left" valign="top" width="41%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></div>
</td>
</tr><tr>
<td valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="41%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><br>
&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: July 21, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block">- 3 -</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!-- Licensed to: TriState Financial -->
    <!-- Document Created using EDGARizerAgent 5.2.3.0 -->
    <!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>


<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="COLOR: black" align="left" noshade size="1" width="100%">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&#160;</div>



<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="30%" style="TEXT-ALIGN: right"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="img123.jpg" alt=""></font></td>
<td width="15%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="55%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="applied.jpg" alt=""></font></td>
</tr><tr>
<td width="30%" style="BORDER-BOTTOM: mediumpurple 0.5pt solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="15%" style="BORDER-BOTTOM: mediumpurple 0.5pt solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="55%" style="BORDER-BOTTOM: mediumpurple 0.5pt solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div>&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">MARTIN GUITAR TO PROTECT AGAINST COUNTERFEITING VIA <br>
PARTNERSHIP WITH APPLIED DNA SCIENCES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dramatic New DNA-based System Provides Assurance that Musical Instruments are Genuine</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="FONT-WEIGHT: bold">Nazareth, PA and Stony Brook, NY &#8211; July 19, 2011</font> &#8211; C.F. Martin &amp; Co. (<font style="TEXT-DECORATION: underline">www.martinguitar.com</font>), an iconic American brand that has been creating the finest acoustic guitars in the world for over 175 years, has today announced that it has partnered with Applied DNA Sciences (<font style="TEXT-DECORATION: underline">www.adnas.com</font>), creator of patented, DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. As a result, according to both companies, Martin&#8217;s customers will be protected by the &#8220;gold standard&#8221; in forensic anti-counterfeiting systems.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8220;People around the world know the high level of quality that is inherent in each and every guitar that features the C. F. Martin logo, and protecting our intellectual property is of vital importance, as we face new counterfeit-related challenges at home and abroad,&#8221; said Chris (C. F.) Martin IV, the sixth-generation Martin to serve as company chairman and CEO.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The two companies plan to announce further details about the partnership, including timing of implementation, later this year.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Martin Guitar has earned an unparalleled reputation for product integrity and a commitment to exceptional quality. Our SigNature DNA technology will be instrumental in providing Martin Guitar with protection against global counterfeiting threats which ultimately protects Martin and its worldwide consumer group,&#8221; stated APDN Chairman, President and CEO Dr. James A. Hayward.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Applied DNA Sciences has a reputation globally for its advanced product verification systems, protecting products as diverse as English wool, Mexican police uniforms, world-famous luxury goods, and, in a pilot for the U.S Department of Defense, microchips bound for the U.S military.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">About Applied DNA Sciences</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators. Its DNA marking systems have been certified and validated at government level, including in the EU. The company is located at 25 Health Sciences Drive, Suite 215, Stony Brook, NY 11790. For more information on APDN (OTC Bulletin Board:APDN), visit <font style="TEXT-DECORATION: underline">www.adnas.com</font>, on Twitter at @APDN.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: gainsboro" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN&#8217;s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN&#8217;s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">About Martin Guitar</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">C.F Martin &amp; Co. (<font style="TEXT-DECORATION: underline">www.martinguitar.com</font>) has been creating the finest instruments in the world for over 175 years. It continues to innovate, introducing techniques and features that have become industry standards including X-bracing, the 14-fret guitar and the &#8220;Dreadnought&#8221; size. One of the world&#8217;s leading acoustic instrument makers, Martin guitars are hand-made by skilled craftsmen and women, who use a combination of new design and techniques along with those introduced by the company founder. Founded in 1833 by Christian Frederick Martin, the privately held company has been continuously family owned and operated for six generations. Christian Frederick (&#8220;Chris&#8221;) Martin IV took the helm of the company in 1986 and is its current chairman and CEO. Under his guidance, the company has introduced a number of new and innovative models that appeal to musicians, including the popular acoustic/electric Performing Artist Series, and several custom and signature Artist Editions.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Martin guitars are the instruments of choice for musicians around the world, from the icons of rock, country, folk and bluegrass to those just beginning their careers. They can be seen across all segments of pop culture, from television (Glee, Psych, Raising Hope and American Idol) to the movies; on Broadway and in books, online, and gracing the pages of popular magazines on newsstands everywhere (including in the hands of Jeff Daniels and Hugh Laurie on the covers of the last two issues of Guitar Aficionado). Connect with Martin on Facebook, Twitter, Tumblr, YouTube and via <font style="TEXT-DECORATION: underline">www.martinguitar.com</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"># # #</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline">Media Contacts:</font></font></div>
</td>
<td valign="top" width="40%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Matt Biscuiti</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chris Thomas</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">The Lippin Group</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Artist &amp; Public Relations Manager</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">for Martin Guitar</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">C. F. Martin &amp; Co.</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">212-986-7080</font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610-759-2837 x2213</font></div>
</td>
</tr><tr>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">matt@lippingroup.com</font></font></div>
</td>
<td align="left" valign="top" width="40%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">cthomas@martinguitar.<font style="TEXT-DECORATION: underline">com</font></font></font></div>
</td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MEDIA CONTACT: Janice Meraglia, 631-444-6293, fax: 631-444-8848</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">FCMN Contact: info@adnas.com</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Web site: <font style="TEXT-DECORATION: underline">http://www.adnas.com</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Twitter: @APDN</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>applied.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 applied.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!&`;`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MBB@`HHHH`****`"BN5G^.O@BV^(Z^#I?&7A6/Q<Q"C0VU:W&I$F/S0/LY?S,
MF,AQ\OW>>G-=50`4444`%%%%`!163XW\?:%\,_#DVL>)-:TGP_I%L566^U*\
MCM+:(LP50TDA"@EB`,GDD"G>#/'&B_$?PU;:UX=UC2]>T>]W?9[[3KJ.ZMI]
MKE&V21DJV'5E.#P5(Z@T`:E%%8>M?$_PUX;\36FB:CXAT2PUF_"&VL;B^BBN
M;C>Q5=D;,&;+*0,#DC'6JC"4G:*N3*26[L;E%%%24%%%%`!1110`4444`%%%
M%`!1110`4444`%%%%`!1110`4444`%%%%`!16;XQ\9:1\//"FI:]K^J:?HFA
MZ/;/>7^H7]PEO:V4"*6>621R%1%4$EF(``K\,O\`@J+_`,'B&E:/!J_@[]EK
M2CJ]U+"L<?Q!UFU>&VMV906:TT^>,/(R[BH>Y"*'0_N9$PS`'[:_&;XY>#/V
M=/A]?>+/'OBG0/!WAG30OVG4]8OH[.UB+,%52[D#<S,JJHY9F``)(%?E#^V?
M_P`'DWP.^#.IVVG_``;\(:]\:IFPUQJ,\TOAK3(E*$XC-Q;O<R2*V`RM;QK@
MY$C=*_G>_:=_:R^)/[9WQ2N?&GQ2\9:WXU\2W2^7]KU"8%8(\DB*&)0(X(@2
M2(XE5`6)`&37U!_P2@_8K_9&_:8U?1Y/V@/VG)OAEJ-U>SP2>%$T*6R$\2QL
M8Y6UR8/96X+#)62/)`VA@S`@`VOVJ?\`@YL_;"_:C_M:S3XE?\*XT#5?)_XE
M?@FR326M/+*L#%>_/?H6906Q<X;++C82M?5?_!II^RU^T_HW[<!^)Z:=XP\,
M?!'6]+N9O%E[K<<MO9>-#)%<"S%L)ES=31W9\WSX_P#5HLRM*OG^7+^UG[#W
M_!*;]F/]BCR/$?P9^&?A/3+Z]3SK;Q")Y=8OBC1LA,%[<R321HZ,P*Q.J,&Y
M!KZ8H`****`"BBB@`HHHH`****`"BOQO_P""X'_!<SXS>$/VQ+;]DK]DW0+V
M_P#BU<>7;:SJD6DI?WL,TUO!>11:>K,T2A+9I&GFGC*QH6(,?E-(/F'XH_#W
M_@JQ_P`$C?"P^./B'XEZA\3/#&F#[7XATJY\1S^)[/38/XOM5I,$*1#<=TEH
MV$`R711F@#^BZBOF/_@DK_P4JT+_`(*D?L3Z+\5;"TM]#U..:72O$>E"8R+H
M^H0!3+'O(&4:-XYD//[N9`3N#`?D)\0O^"LO[9O_``7H_:?\2?#S]CXZA\-?
MA9X><-+K<9_LN\BMW4"*;4M0!D:!Y)(9C%#:;7*%U(E$;NH!_0O17\[5E_P4
M0_;N_P"#>SX[^&M*_:<N=0^,?PD\3SB,W]QJ3:P\R`[I6L=0DVS)<H&SY%U\
MKJN`%!$J_KQ_P4@_X*O^"/V#_P#@G;)\?;":R\7V/B&UL_\`A"[:*X\J/Q)<
M7L?F6NUB,B/R=\[\;A%$^!NP*`/JVBOYT_ACX(_X*L?\%?/")^-OA[XD7OPP
M\+:@3=^'M)M/$%QX6L]2AP,?9;:$,\L/RC;)=N0X.0[*2:^E_P#@B!_P7,^,
M_B7]L:?]DG]K/0;RQ^*T`DM=&U6;3$L;Z2>&WFO)(=0"L(G#VRQM!-#&%D4*
M29#*LA`/G?XM_P#*[M:?]AK2O_40MJ^U_P#@MM\;OV]_AS^V[\&M*_9;\+WN
MK>`+^T22^DM]&BOK"^U+[4RS6^JSOG[):+`+?:VZ#(FG*RED'E?%'Q;_`.5W
M:T_[#6E?^HA;5Z]_P<K_`+??QG_98_X*4_`7PK\.OB3XI\'>'/$6DV<VIZ?I
MEV88+UWU66)F<=R8P%^@H`_;^BOSQ_X."O\`@MO)_P`$C/@[X<T[PCI%AKWQ
M4^()G;14U!1+IVDVUO)`)[FYC25)6+"79"HPK.KLS$1&-_SET7]C_P#X+`^+
M_AROQP'Q0\966MRP_P!IQ^#+GQ*+74GCV\#^R#&+%&*?-]G?;)GY3&)/EH`_
MHHHK\W_^#?/_`(+?7_\`P5,\"^+/!_Q(TK3?#?QC^&P234XK?%M!K=F\CQ_:
MHK=W,L4D+JL=PN"BO+"P*^;Y4?PA\:?^"NG[8'_!<K]J[Q%\+_V,'U/P1\*]
M"E`D\26\#:5>&!D&VXU#4"7:U$DL,Y@BM_+E="P99"C;`#]`/^#J/_E"+\5?
M^OW0_P#T[V=:G_!KY_R@O^!W_<>_]2#4J_%__@J]J/[?O[!_[)>L?!7]H[7?
M^%C_``K^)=W:+9>*KJ\DUP6]U:SI>"&&^;9/'(YC&8[M3O2-S$/D=A^I?_!$
MS]JO2?V-?^#:_P"$OC;5(5OIK8ZW:Z=IXN$ADU*[D\0ZD(XE+=@-SL5#,L<<
MC!6VX.^%PU7$5HT*,>:4FDEW;T1E7KPHTY5:CLHJ[/U0//<BORY_X*>_\IF?
M@-_W+7_I\N*YWP):_MH?\%#]/;X@Z/XKF\%^&R3)IL5OJDVBV%V`=K+#%'OD
MF4,GWIR5R2%8\@>-7_Q0^)GQ)_X*4?"*V^+MM]F\<^$_$>@Z'>!X$AFD1=26
M='D$9\MF*W'#1@*R;"`<EF_4.&^%YX/$5:OMZ<Y0I5>>,97E&\&NUGJ[.S=C
MXG-\[6)HTX>RG%2G%IM63U_5:G[FT5\2?\%>_P#@HCXA_93L_#W@KX?RVJ>-
MO%$;7,UPT'VB?3K7=Y<1BC(*M++*&"E@P`B<;264CY:\>W_[9?\`P3\TW2?B
M1XF\3:QKFC7TB?VA97VK2ZQ96#OG;#=19VPAF8J&@8)NVC>"4!^8RO@W$XW#
MTZSJPINJVJ<9.TIM::*VU]+OK\CW<;Q!1P]65/DE)0MS-*ZC?NS]@**\)T#]
MOWP?=_L-P_'C4(=3L_#9M#--9I$);I9Q<FT^SH.`Q-P/+5B54@AF*KDCX/\`
M"WCO]K__`(*AW]_X@\(ZO/\`#WP="Q6R:UO9]'L6PY!6*XC4SW#J8\.P)4-D
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MXI?"6;[9%XDTEO&VJZY(5;3[D6SK'J%NH`6[-N<Q.&..05S6U_P7\_X+X>)/
MV!OB%X;^!_P)TC3?%?QM\5I$]R6MVU)M"6X;R[2WCM(SF6^G8ADC?.U/+)CD
M$R8\<]$_56OR_P#AA\9OVZK[_@X5USPCXDT?5X_V68A>>5<VN@Q+H,5@-,=[
M*6._DA622\:[,`E02.0[S*%\I%*^9_\`!+#]FK_@IJ?VS_A_X^_:&\>WR_#)
M7NI]?\/76O6?F2))8SI`#:6B^4"L[0MM!!4J21D$5F_\-T?&#_B+^_X4I_PL
M/Q/_`,*G_P"A6^U'^S?^1*^V_P"K_P"OG][_`+W-`'[/45^/G_!=O_@N5\5_
MA3^T_8_LI_LJ:+?:O\9=0BC37+^#13?WNFO/##=P0:>C$QM+]E+R32R1/'%%
M("I#J[1?*OQ1^$G_``5@_P""6'@23XZZS\3M5^(F@Z.IU#Q'HLGB.7Q/!I=L
M/]8US9S*%6$!CO>S8^4JLY:-4W@`_HMHKXU_X)U_\%D/!?[:_P#P3)U;]H;5
MH!H`\`:=?S>.=+M`]PVD7%A;FXN!$&P9$D@V2QC)XE"%BZMC\@OA;^TG_P`%
M'/\`@X4\<^,/&'P@\9S_``B^'_@ZX^SVUKI&N7/A_3(YF3<MDMU$IGO;KR]C
MR%SY:&16Q`LL:$`_I'HK\:/^#?G_`(+8_%KXD_M5>(?V4/VHC*?BEH8N;;0M
M0N+)8K^YNK/SY+VSO'C;RY'6%0\4B(%9+>0L[ED+6?\`@N)_P7D^,'PL_:\B
M_97_`&4_#=UJ_P`6&C2+6=131#JE[!/-;0WD,6G19:-F2V9WFDFB=$5C@*8V
M<`'['45^0W_!*;]D3_@I+X(_;9\%^,/VBOB9+J7PQMHKXZYH4OB:&[>1I+&=
M+=?(@0Q,5N'B;Y7P-F<G`!^>/VL/^"QW[5/_``6'_;0U[X(?L1R7V@_#[0+A
MX9?%FG)]CN=0C0$/>W-^Q86=H\D;^0(_+EE4C=N9_)0`_H`HK^=#QI^UK_P4
M4_X-Y?'_`(<UCXWZY/\`&[X4^(KH6T\U_J\^MV,T@P[P)J$J"YL[HQ[S&)1Y
M;[7(241.%^S/^"\O_!?&Z_9>_8!^$7BKX"7ZR:S^T3;37^@^(GMX9TT73K>*
MW>Y/EN65;T/=P1!'1Q&5GW`.B@@'ZQT5^#?P(_X)<?\`!4/P!=^&?B;I?[5=
MEX[LKA[74I]$3XCZCK*7]M(Z&2.)+R`Z>Y\MFY$@3Y?D<_*3^W_QG\$WOQ+^
M#WBSPWINK7.@ZCX@T:\TVUU.W8K-ITLT#QI.A'(9&8,".ZB@#^5K_@X*_P""
MY>M?\%._C9>>"_!.IW=E\"/"-\RZ-!&DUI+XFE"1*U[>1F1ED42I(;<,B,D4
M@+*LC,!RG_!,G]@#X1ZAKZ>*/VF+?XC3Z#%Y4UAX7\+Q00SWQ$C>8M]--+&\
M,955`2#]XPD)\V(IAOD[X:W$W[*'[6/AJZ^(7@>749/AYXJL[KQ#X1UNV^SM
M>K:72/<:?<1RHVT2*C1L'0C#'*GH?W_^"G_!8WX'?M%>'VU+P9^QY\,M=AB"
MF>*WALWGLR2P"S(NG$QDE6QG@XR"1@GZ;AC+:.,KRIU:4JMEHHSA!^MY;^B/
M%SK&5*$(NG-0N]W&4OEHM/G\CP/]KG]E#_@G9^TGJ#ZEX<\`?'3X1ZPT+*!X
M5735T^>3`"O):W%S*H"X^[`8=V3DY.:_,WXY_P#!-?7/!6O:A)X'U=O&?A^%
M_P#0Y+RT32]3N$VY+-;"6:)2#QA9W)X]<#]XA_P4)\`B6-'_`&&_`R&3H/L%
MON([X!TSFF)_P4.\`2;-O[#O@-O,SLQ96QW8ZX_XEG.*^RGPA1E%\F`J*^S]
MO2?Z:]?ZW^?CGE>,ES8F/I[.?EY>:^\_GO\`@-^TQ\=/^"=WCQ=9\!^*/'/P
MPU:=EEE2%Y+:WU`)O5?/MY!Y-PJ[GP)$=022!FOU$_8]_P"#S_XK>"M7L-/^
M-O@#POXXT&.-(9]4\/1OI>L9`.Z9XV=K:9CQ\B+`O7D<8^P-9_;M^%_BO3Q:
M:E^P?\.-2LY\GR;C2[2>.3'^RVF$'%?$/[:G[$7P*_:>O[O6O"G[./C?X+^(
M+M6V#PUK[MI$DQQAGL9M/8``#`CMW@!R3R>OS=?@3-N>U*CIVE.G?3?[?XZ?
M@>S1XDP;A>I/7RC.WE]D_2;X1?\`!V3^S'\9@8M-TGXG6-^76-+'4+#3K>XD
M+9P%'VTJ^<'[C,1QG&1GT@?\'"_P=)`'A3XFDGI_H5A_\EU_,1\5?^"9GQ=^
M&@^U6/A76_$E@"?WVEZ=<32QX&26C";@/==P&1DC->K_`/!-W_@M-KG[#^IQ
MZ1XV^&?PX^-W@:6;,]GXGT6WEUBS7:X_T2_>-G7YF0E)EF3;'M01Y+#BIPP&
M#D\/FN&GSKM.WX.+^].WD:SEBL2O;8"O'E?>-[?._P"#5S^B%?\`@X6^#;(#
M_P`(K\3BQZ`6-@0?_)RE/_!PG\'-@(\)_$\MW'V"PQ_Z65\@?`G_`(+0?`O]
MI70GO_!G['/PXU86X7[3;+!9-=69;=M$L::>VW.QL')!VG!.#7=)_P`%"_`,
MJJR_L.>`V5SA2+*V(;Z?\2SV/Y5]=A.&<'7I1K4L#4E&6J:KTK?EWO\`D>'6
MS;%4ZCI3Q$5):->SG_EYK[UW/OW]BG_@H;X*_;N/B)?"6G>)=,E\,"W-W'K%
MO#"S"?S=A3RI9`1^Z?.2#P.*]XK\M/AK_P`%A8/A#;W$/@[]E#3O"T6IL&F3
M1KH6*W14$`L(M/7<5!/)SC)K[`_X)^?MVZG^VYHWB.YU+X=ZMX%.@S0QQO<7
M#W-M?B17)$<C0Q9="GS*`=H>,Y^;%?+9]POC,)SXI4'3HIJW-.$FKV6O*]=>
MR_(]O*\ZH5U"A*IS5'?:,DGUZKM;K^9]%T445\F>Z?SB>!?B-H?_``2O_P"#
MM'X@ZY\;[BS@\.^--3U6\TWQ1JT<HM]%@UB(W-G<Q2.GW(]QT]Y%_=Q@S@L%
MC;'ZV?\`!2K_`(*U?L[_``#_`&'?'NMZCX]^&?Q!76/#MU:Z=X6LO$%EJ$WB
MG[1']G6%($D9I8&:91*R@A(B['.,'K?^"F/_``2`^#'_``5:\$Z?IOQ,TO4K
M36=%;.E^)-$GCM=7TY"P+PK))'(CPOCF.1'4$EE"O\P^)/A-_P`&9?[.?@GQ
M*VH>(_&_Q/\`&$$6_P`BPFN;2SM261E4R^5#YC[6*N`KH"4`8,I*D`^.O^#;
M3XAZOH/_``2(_P""@T-K>W,,?A_P;<:M8A)67[-<OHNJAI4Q]UC]FAY'/R+Z
M"NX_X,]O^"@_P;^`OPR^)_PL\=:_X0\!>,-9UR'7].U;6;R&P_X2"V-ND'V,
M3R;5+6[QLZQL^YOMLA13MD(^S](_X(R>`/\`@D!_P2N_;)M/`GB?QCXE3Q]\
M,]9EO3KTELYMS:Z1J(01^3%'C/VA\[L]%QCG/YF?\$`?^"$OP@_X*Y?L4>,]
M?\<:KXQ\,^*?"WC*73K/4]`NX4\^W:RM)!%/%-%(K*CF1E*;&S(V688``/JC
M_@[J_P""C_P=\?\`[&_AOX.^%/$GA+X@^,]7\3Q:O,VD:E;:BOA>*TB<-)*T
M4C-#<2_:5C12OS1M<$D84-\R?\%W/A+XU_9/_P""'?[#/PK\976HC6;9-0U+
M5K.Z9EEL9S%'-%:2*>CVL=\]OC^'RR!Q7Z8?L$?\&K?[.?[$GQ;TKQYJ-UXG
M^*?B71&,MA%XF^ROI-G/R%G6T2(!Y%!RIE>0(P5U"NJLORS_`,'OO_)+OV=_
M^PKKG_HFQH`^_P#_`()A_P#!6K]G;XX_L'_#K5++X@_#7P!)H7ANST_4_#&H
M:_9:=-X9>VB%NT)ADD5DMP86\IR`'C"L,<@?D[\5_B+H/_!57_@[+^&NJ_!"
M33+G0/`FJZ1<ZIXHTI9&MM=AT;_3+R[DE1.5<*-/CD),<@2W`<I(M?2F@_\`
M!H'^SW^T%\./!?C72O&7Q+\%2>)M#T[4[_2[.YM;NRCDEM(FD$'G0F6,,Y9L
M/)(`6(`"@*/T#_X)F_\`!'[X+_\`!*3P9J.G_#/2M1O-;ULXU3Q+KDT=UK&H
M1AMRPM(D<:)$IQB.)$4[0S!F^8@'Y"_%O_E=VM/^PUI7_J(6U)_P=J_\I:?V
M:_\`L"6'_IYFK]1O$W_!#3X<^*/^"L47[7DWBSQK'XZANK:[&CH]K_9):'3$
MTY1CR?-P8HPQ_>?>/IQ1_P`%(O\`@AE\./\`@II^TCX#^)OC#Q9XWT+6/`%K
M#:6=KH\EJMM<+'=-<@R"6%VR68@[6''OS0!^4'_!Z=\#=?T?]LCX._$^<S)X
M/UOPI_PC,=Q;JTDEG>6=]<7,I8?*BEXKZ(QC>"YAEZ!,TW2?^"9*Z]\)(_'-
MI_P5IT0^&I+=;G[5/XANK=HPRAA&\3ZH)8YL$#R602!CM*AN*_?+]J_]DCX>
M?MO?!/4_A[\3_#-CXI\+:J5=[:?<DEO*N=D\,JD/%*N3AT(8!F&<,0?RT/\`
MP95?L^_\)091\4OC(-#/_+IY^F_:NG_/?[)L_P#(5`'D'_!N%^QI\)_BM=?M
M,:_\,_C5\0_'OQ-\1>"KKPI>>)+_`,./H=MHO]K,\BW&Y[B>:XNGGM%E$F5V
MB)\@EP:X7_@T=_;4^&G[%GCKXX?"KXO:OHGPL\9:Y?V$EK-XF<:2]Q+9FZAN
M+">2?8L4T,D@VQ2$.6FF`&5(K]U/V,/V)/AI_P`$_P#X&V'P\^%?AJU\.>'K
M.1KB8K^\N]2N'QON;F9OGFF8!5W,3M5$10J(BK\K?\%,/^#;_P"`'_!3+XI/
MX^UE_$W@+QW<P^5?:IX9FMXH]9(VA)+N&6)UDD15*AT,;D$!V<*@4`^8?^#K
MW_@IE\$]:_8!G^#>@>(O"/Q"\=^--6M)X$T?4K746\*I9SQ3R74QC9S!)(A\
MA%.UG2>8@E58%WC3]BSQE^S;_P`&\G[.OAW6M.N[34/!DPUGQ#831/!+I)U2
M6ZN52>.0*R2Q2WL<#H5RLCL.@)KV']AO_@U$_9O_`&/?BGIOC36[GQ-\6=:T
MG<UK9^*%M)-&BD(($ILTA'F.H)V^:[J&PP4,JD?I?XA\/:?XNT*\TO5;&SU/
M3-1A:WNK2ZA6:"YB889'1@592"000017JY'FCR['TL<H\W)).W==5\T<.9X)
M8O"SP[=N9;^>Z_$^9O\`@G?^VM\,/%_['W@2T;Q9X<\/ZEX<T6UTB_TO4=1@
MM;BTEMXEA)"/(6,3F,LC$DLI&<,&4?'WQM\::+^VW_P6N^')^']W97]AX;N=
M-^TZI&P>UO\`[!/)?SRHZ`[EV?N58\,Z*`=I5C[GXY_X-^/A5KWB"6[T3Q)X
MR\/V<SEOL(GANHH!V6-I(_,QU/SLQ]Z^@_V//^">WPW_`&)+*Z;PC87=YK-\
MABN=:U1TGU"6(L&\D.J(J1Y5?E15#%%+;B`:^N68Y%@'6QN7SJ3JU(SC&,HI
M*'.K-MI^]9-VMUW/G_J>98E4\-B81C"#BVT[N7+V72_R/BC_`(*@(LO_``66
M^!"LH96'AL$$9!']N7'%?4G_``6>_P"4;WQ!_P"NFE_^G2TKHOC[_P`$ZO"7
M[0W[47@_XKZMK/B*SUSP9]@^R6EI)"MI-]DNWNH_,#1LYR\A!PPX`Q@\UZ!^
MU)^SGI/[5_P+UGP#KE]J6GZ7K9MS-<6+(+A/)N(YUVEU9>6B4'*G@GOS7G3S
MK#.>6R3=J"7/IM:HY:=]&=<<NKJ&,5OXE^77>\;?+7N?GW;>%;[Q5_P;HVPL
M(;^YETZ:>^EAM59R\,>ORM*SJH.8XTW2L>BB/<2`#7LG_!'']K'X<P?L6>&?
M!U[XJ\.Z'XC\,O>QWEC?7R6LK^9=S3+,@E8%U*3)EERH8L.,`5]/?LP?LX:-
M^RK\"-&^'NC7FH:GI.C?:#'-J!C:>837$D[AMBJI`:4CA1QC.:^7_C#_`,$$
MOA+\1_&FH:SHVK>)_"*:G<&=].L6MY+"UR!N6"-X]T:ELG;O*KG"A5`4=LLZ
MRS&TL3@L;*4(2K2JPFE?>ZM);ZJUM=&<T<NQN&G1Q6'BI25-0E%NVUMGMN?*
MG_!=3]J/P'^T+\2_!^D>"]4L_$$GA*TNCJ&JV$D<]E.;@6[QQ1S*2)2@C8MM
MRJF3&=P=5^BO^"U'_!,O]GC_`(*D^*O!?@SX@?$[3/AK\8M)LIYO"KPZA91Z
MCJ-K,X#H]I,5DO(%>%B%C93&Y8A@'8/M:G_P;]_!V\T"PLX==\=6US;-*UQ?
M"]MWFO-^W:K*8?+54PVW8JD[SN+<89_P5Q_X(&_#C_@KMXQT#Q1XJ\9>-_"?
MB;PQI1TBPDTIK:6Q,1E:4M+!)$7=MSGE94&,<'K7'Q/F&65<'@\'ELI25%33
M<E9N\D[]M7=I7=E9,ZLEPF,IXBOB,7%)U.6UG=:)Z?+1>;/R2^&^L_M*?\&]
M_P#P5@^"_P`&KSXTCXK>!_%VI:?92>%++5;N^M1IU]=BT93ILKC['>C<983&
M2K,L>6D4R1UV?_!3;QE;?\$T?^#K/P[^T#\6O#6HW'PK\1?8]3TZ]@LQ=)*B
M:!'I,DR!AM:6TNPLS1J3(JB)@,O'G[R_X)Q_\&MWP4_8(^/FB?%'5/$WBGXH
M^-/#4C7&E?VS#;PZ98W&,)="V569IX^L;/*P1L.JAT1E^P?V^_\`@G'\)?\`
M@I7\'9/!OQ4\-0:I#"K_`-F:M;JD6KZ#(Y0M)9W!5C$6,<>Y<%)`BAU8#%?&
M'T1N_"?]O+X'?'C7K'2?!'QC^%GB_5M3W?9+#1O%5C?7=P51G8+%'*SDJBLQ
M&,@*Q.,&OQ@_YWH/\_\`1/Z^ROV&?^#7;X)?\$__`-KOPC\8?!WCGXJ:GK'@
MV2ZDM+'6;NPFMIO/M)K9A(8K6-CA)F(P1R!VR*]C_P"'*GP^_P"'N?\`PV-_
MPE/C+_A/?^@-YEM_9'_(%_LCIY7G?ZGY_P#6??\`]GY:`/P?_P""R?P@U/P-
M_P`'(7C*V\5?$[Q%\&--\9ZA::AIGQ">TN5%A:7.EQQ)+$T;Q.]LDPDLGEC?
M:@BESGRV6O3?VHO^"<ME\!?V?]1\5^+/^"I5IXD\.7=MY1TS1]4N-:NM;BE9
M8FCM[6/56:Y7]Z-X`*JA9F(4$U^YO_!2;_@E3\(/^"J?PJL_#'Q1TF]6ZT>7
MSM(U_2)8[;6=&+,IE6"9XY%V2!`KQR(Z-A6VAT1E^"_AI_P9?_LZ^%O&D>H>
M(O'OQ5\5:5;RI)'I9NK.RCG`(+1S21P>8R-R/W9B8`\,#S0!P7[#?[.WPM^!
MO_!LA^TWK?PJ\0^-_%UGXST#7I=0\0Z_H+Z$FJRP69@Q96Q=_P#18_GB+^9(
M6F2X!8;1&GI__!F%&L?_``2O\9LH`+_$_46;W/\`9>E#^0%?HK\7/V*?`WQ*
M_8Q\2_`C2]-M_`_@/Q#H%SX=2U\.VL-FNF6\ZLKF"/88U;+,W*D%B20237$_
M\$M_^"8_@[_@E!^SSJGPW\#Z[XF\0Z1JNOS^(9+G7)('N4FE@MX"@,,<:[`M
MLA&5SEFYQ@``_)F&!+?_`(/G2L:)&I8L0H`!)\`$D_4DDGW->9Z5\3M%_P""
M5?\`P=H^.?$WQMF@C\->*M6U*]L?$M_!,T.D6VL6QEM+F)F3)2+S/L,CK\D8
M%P-VV,BOU[_X<J?#[_A[G_PV-_PE/C+_`(3W_H#>9;?V1_R!?[(Z>5YW^I^?
M_6??_P!GY:Z[_@I5_P`$C/@O_P`%5O`NGZ3\4-'OX=5T5LZ5XCT6=+36-,4L
M"\<<KI(C1OC!CE1TR=P`8!@`>E_##]MOX+_'/Q!::-X)^+_PP\7:OJ(<VMGH
M?BFPU"YN`B%W,<<4K,VU%9C@'`4D\"OY,_\`@F;^S5J>M?M+>-/A1XM_:1U;
M]C[Q39MY$YU1I].M-2NK9Y$DL[F5;JW6*>,N3&LF0^^0*0VU9/WV_8!_X-B/
M@S_P3J_:Z\+_`!A\'>.?B=J^M^%%O%MK+6;FQEM91<VDUJV_RK:-LA)F(PPY
M`[9![K_@IY_P;S_`3_@J/\08?&WB9/$/@OQXL(@N]=\,2V\$NLJJ)'$+U)8I
M%F,:($5QLDVA5+E415`/Q6_;^_89\$_LZZ'IOA_XJ_\`!234/B'8Z]/^\T+0
M[&Z\5R0"(+();BW75&CB7+1[#*5+DDH"$<K^L/Q<_P""8?[(/C[_`():_`O]
MG_XB^)[OX<Z3]A.I^`-2\5ZC::'XOAN9F6ZNPJW2X$LK70\^T*'&]1L1XHVC
MS?V+?^#2[]FW]E3XH:;XP\17OBCXM:CI19H-,\3)9OH;.00'DM%A_>E<Y"R2
M,F<$J2!CZ*_X*S?\$9OAS_P5^\-^#K+QYXB\9^'+CP')>2Z5/H,]LBLUT(!*
M)EFADW@"W3`4H02<D]*`/PJ_;5^`/[1W_!K_`/%OX=:G\/OVB#XD\'>);RYO
M=*T.&[N;>TOE@\LRKJ&D-(T#Q2"XVB1'9MVY@T3A&K^HK2[XZGIEM<F">V-Q
M$LODSKMEBW`':PYPPS@C/6OR2_92_P"#/3X%?!#XLZ1XK\=^-?&'Q7CT*Z2[
MMM#O[:VL])NRF2L=W$!(\\8;:WEB1%;;APZ,R']=*`/S>_X+;_\`!NWX%_X*
MG1W7COPM=VG@/XW6]H((]6,873?$>P1K&FIJD;2LR11^7'/'\Z*0&654C1?Y
MUOBK\#OVH?\`@B)^T67OH_'/PE\2PS/;6.O:7-+%INO1IY<C""Y3]S=PD-&7
MC.X#<%D16!4?VE5S/Q>^"W@[]H'P+=>%_'?A7P[XS\-WS(\^EZWIT-_9RLC!
MD8Q2JREE8`J<9!`(P:`/YR?@[_P>/_&^TL[:R\:^%?A[=21HJ'4;'1I1)*1P
M7DC-RJY/!.S`ZX7H*^W?V9?^"UOQ]_;'@@/PPTOX/^-+J>%I_P"S]/DB.I1(
MK,I:2T:^%Q$,J?OQKD<C@@UR?[>G_!FI\-OB3;:GK?[/_C'4OA[K\[F:'0/$
M$K:AH)^50(HYE4W5NN0S%G-SRV`H&`/R5_:J_P""$'[77[`GCA+FX^&_BGQ!
M;6#&>U\3^`X[C5[--BJQE\R!!/;;2V,SQQ$D'&0,U[N79U##1Y:F&IU/.4=?
MP:3^:OYGDXS*I5I<\*TX>2EI]SV^6GD?OM!^T[^WC(8@OP7\*_,"039<?B3?
M?SH'[47[>,1"'X+>%CM)!_XE^[]?MO-?SN_#[_@MK^U;\.%6V;XZ_%'6;2(L
M#;:MXFO[@Y.1S)YPE&/3?CVKW_X+_P#!??XA^);^UT_Q?\4_BCX7,\JQMJ,?
MBG4[FR@4]9)$C=IE`XX1)">?I7T66YAEN)LJM.C3?]Z,[??&^]OQ^[Q,9E^,
MH_PZE6?I)?D['[3M^U!^W?!A9/@KX6+'GY+$,/S%[7P9_P`%'O\`@D!\;/\`
M@HGK;^*;K]GO0/`?C=/,DGU;PQ8P:>=9D<@@WL?VAEF;.?W@42?-RS``5[9^
MS/X/^,/[9-O"WPN_;4\$>-KJ:#[4=/T[XJZPVI0Q9(W2V;1"XA&0?]9&I[].
M:^(O^"BO_!5KXE_LA^*9O!_A#]I;4/B7XI$:FYU+PIXYU/4])TLE0=K7#%(Y
MI@I`VQ%U0DAR&0QGU,94RF.&DE+#2LOLQJ*3]'9:_-')1I8]U%;VR]91M\_+
MY'P;^R;^UE\5/^"3?[9/_"4>%+D:-XQ\&7USH^LZ7=.9;'4%1VAN+*[CC<+-
M'O4G&?E>-)%(9$8?TIV?[4G[=VH6\#P_!KPF\4B"1&^QC:P(Z@F^YS_+FOYT
M/^"7'_!+WXF_\%9?VCI/"_@^T<Z7IJ_;_$_B._=X[#2(FWE!-.$D/GSLC)&@
M5W8[WV[(Y63^@I/^"8/[9UJ@"?'[/;Y?'NNC_P!H"OF>&(X3]Y];E26UO:*;
M[[<J?SO^A[>>*NW#V*J/>_(TNV]_P.C3]J3]O!54?\*5\+X[_P#$N)/_`*6U
M-%^U;^WA&@`^"_AM2>NW3\#_`-+:Y?\`X=F?MH_]%]D_\+_7/_C-'_#LS]M'
M_HOLG_A?ZY_\9KZVE_9$'?VF%?K&J^W]W^KGSSIYAVK_`/@43Z#_`&+?C=^U
M?\1OC-%9?%7X=>%O#/@J.VEDN[Y8VM[E9-I\I(0+B7>2^-P90H4,=P;:K?7]
M?EY_P[+_`&T<D_\`"_'R?^I_US_XS6IX*_X)O_MFZ-XPTN[G_:#^S6]O=1O-
M*_BW5M2$:;OF;[--"(IB!DB-R%8C!(!R/G\TRC+J\W6I8NA#3X8JHE^,7J>Q
M@<?C*%-4YT*D_.3C<_2^BBBOA3ZH\I_;P^%6M?';]AWXS>!_#=O%=>(O&7@7
M6]#TN&2584FNKK3YX(49V(509'4%B0!G)KXR_P"#9G_@G'\5_P#@FK^R=X]\
M*_%O1;#0];U[Q:VJV<-KJ4%\LEO]CMXMQ:)F4'?&W!.>*_2.B@`K\L/^#GS_
M`():_&/_`(*<>`O@_8_"'0].URZ\'ZAJD^I)=ZI;V`B2>.V6,@RLN[)B;@9Q
M7ZGT4`<=^SOX0O\`X??L_P#@70-4B6#4]#\/6&GW<:N'6.:*VCC=0PX(#*1D
M<&NQHHH`****`"BBB@`HHHH`*\_^,_Q=F^&GC'X>V$<$TT'BK79=.NC'937+
MK$FFWMR"GE@X8R01CY@?E+\<;E]`KB?B_P"&Y-0U?P=K8\XVWA'69-4NXX8G
MFEGB;3[RUVK&@)<AKE6VXR=O&2`#I24>;WE=:^733\2*CDH^[N9Z_'SP]X5U
M;QTNJZC>+!X5N89M2E%G<3P:7%);0N`[HK*NU3YCC(,:.LCA48.W5:Q\1-+T
M3Q-8Z-*U[-J6H))+'%;64UP$1.K2,BE8@3PID*[B"%R014?A;2&TZ_\`$\S0
MB$7^H"97*%3*HM8$W$XRW*$9YZ8[8KS#5]-OOA;XRUSQ#JE]XGBTG7K:P\N7
M0]*;5;R-XH?*>U>".VFF$2D&59%)0M<S`JA`:7HC3IS;MT2Z[O3;3U[O\SFJ
M5*L;**O=OILM?/TZKOY'K7@_QG8>.M(-[I[7'EK(\+QW%M+:SQ.IP5>*55=#
MT(W*,@@C(()GM?$MC>^([W2(I]VHZ?!#<W$6QAY<<S2+&VXC!R89.`21MYQD
M9X_X/^$[NP\2>(]?N9+YXM=-JMLUX/*N+B.*(XFFA$40BE+2&/:4+[(8RS](
MX\G7/%`^$OQWU_6=6L-:FT;Q'INE6-C/IFE7>J.;J*2_,R2);12-"BI)`1))
MM4F0C/%92H^\XQZ?\#TVZZ=#2%9\L925KNWYV[[^O4AU[XGBX_:$\&3V-[J,
M^A77A;Q!++;V\4TBS30W^CPJ[0J,LT9DE4-M)4.^#AB3U>D>.CXDUC03!>O:
M1W,,YGL[C2YXYKIE2,[HW?:%5"XZJV_<,$;37`?#7P3KME\1/AE>ZGH]SITT
M7@S7AJ,3,DRZ7=W=[I$XM7E0E&==LR@J2&\ER.*Z3PIJ5WXH\0^#;JXT?5M,
MN-.TVX@U&WNH2/L,[PVC^5YJYBDP25$D;LC,CA6)4XUG"FXI)[)_^W?\`SE6
MFN5VWM=6>[<?R3>GZ(GL?VJ/`VJ7.@16VKRW#>*_-.AF.QN&765C<*[VYV8E
M0*?-#(2IAS,"8@7K8_X71H#^!D\1)+J$NG/</:!$TRZ:\:9)7B>,6PC\\NKH
MX*A,@*S?=!-<#X,\$:A;>`/V>X+C2KI+CP]]G-^CVY#Z>1H%Y`QD&/D_>.L9
MSCYG`ZG%=)X]T#4-.^)&@^+(X)K_`$S0%OXKRQ1&:1!/'#MO8D56:66+RGB"
M*`QCNYRI)`CDF<*/-RQOUUNO/R6^@J=2NX.32OI;1Z72OUUM=]NQT-I\5-)O
M=9U73%_M&/4='@2YG@DT^=&DC8'#Q90"<#&#Y1;:<`X)Q7$_`G]INS\:_L]?
M#WQ/XB,EEK'B[2=.E:W@T^YQ=7MQ:K.\=M'M9Y5`$C97<%2-F9MJLPIZMXXN
M_B5\7OAIJ^@:!JXT6UU"_MM1U*_TR[TR[A1["X*P?9[B%)/(>2.-GD?:OF1V
MX42$G9Q_PM\(:S\+/AW\,K"_T_Q!;3_#;PJ?"^MWFDZ<+JYMV6WM"LELA@D:
MZMI39\BW+2J[P!H^'\K2-&G:SNF_-7^UIMULNE]?-$NK7YF[:*ZVW^&SU?2[
MZVT9[UX9^(^D>+=?U;2;.XF&J:&8_MMI<6TMO-$L@)CD"R*I>-]KA9$RA:.1
M0VY&`=XL^(.E>";O3+;4)YEN=8N/LMG#!;2W$LS[68X2-6;:%5B6(PH')%<'
M\,--;QM\2K+Q1#+XLN-,TW1Y[*UN-<T_^S6F:>XB,D:VS+#,AC^QH2T\&")D
M\IR#*#<\8>&[^^_:U\#:G%9W3Z99^$?$5I<7:QDPP2S7>BM%&S=`SK#*5!ZB
M)_0UG.E!3Y;VT;]'9Z?/3II>VZ-H5IN',XZWM^-K]=O4UM0_:"\*Z;H.H:M+
M?W!T?2;MK*\U%+*>2SMY%?9(6F5"@CB?<LDF?+B*.'9-C[=34_B=I&E>,;70
M&ENKC5KJW:Z$%K9S7(AB!(#RO&I2(,0P3S"N\HX7<4;'CWA'Q#?^`O".F>%!
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M7P7KL:NEIX+\27>L7D*PR33SP/I]_:`1(BEF;?=1M@`DJK8R<5FJ5.,[2U5N
M_>-[775.R]=RW.;7,M/EV>^^S6N^QVOA_P`:Z;XIU+6;*QN&FNO#]VECJ$9B
M=#;3/;PW*IE@`W[FXB;*DCYL9R"`G@/QOIGQ,\#Z-XDT2Y-YHVOV4.HV$YC:
M,SP31B2-]K`,N58'#`$9P0#D5YOHWB(?!7XN^,O[6TWQ#=6_C_6+74]*N].T
MBYO[<D:?96+PS/"C"W97M0Y>81QE)U*NVR4):_89;SOV*/A`3AE;P5HX]L?8
M8145*"C3]HO[MOFFW]ST\NIJJMZBAY-_<TCI;GXL:3KMSJ^E:;)J%S=62212
M7$6GW!M%D5&+*MSL$+,I4JP5R58;3AOEJ/PC\=_#'BT>'H[+4'9/$\4LFDS2
MVTT,.I")=Q$4CH%<LF9$`.9(T>1`R(S#E?@VUW\*?@WX9^'>LVFKW&O:5I!T
MB.[BL;BY@U!;:)HUNY)T5XX6G2,2^7))N#2;,LW)[;QAHIO]6\'NMKYILM4,
MQ<1Y^SC[#<IOSCY?O!<_[6.^*=2-*-X[V;LTUVTZ;/\`SZF-.=5OG?6VEGWV
MWW773[D5M3^._AO2M/UF\DGU&6QT"X^RWUU;Z9<SP1.&"OB1(RKK&Q(D="RQ
M%)`Y0QN%O>,?BEH_@C4--L[U]1>[U??]FBLM-N+V1E0`LY$,;[$7<H+OA064
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M6Y$94QR,Q3<'7=L`!^I_[;W_``3+_97_`&DO!WB'7?C-\-/AM%%+$L^J^*[B
M&'1M0@2,KM>34XS',BC"CYI=I'RG()!_E_\`^"I_[+G['_[/GB2_3]GG]H/Q
M7\3KL7+6ZZ')X9\^TL"CJ)&DU@O;Q31LI<QFVMI@=F&<`AZX*VA_:D_X+.?'
M)8D/Q*^.7BV-PN6>2YM-&65B1DDBVL8696ZF*/(/I7Z#_L0_\&:?Q>^+.G1:
MO\<?&>D?".V\U"-#TZ.+7M6EC$CB19)8IA:P%D561TDN/]9\R*5*D`_&JQO;
MBPN!+;3302A6&^)BK`$$,,CL02#[$U^I7_!+;_@U:^-7[:.H6?B3XMV^J?!/
MX<R(ES&^H6B-K^LKYI5HH;-V#VORHW[VY5<;XV2.92<?O7^P-_P1&_9O_P""
M;][!JWP[\`6LWB^*!(6\4ZY,VIZPQ574NDDG[NV9Q(X?[+'"KC`92%&/K*@#
MS;]E#]D+X<?L/_!O3_`7PN\*Z9X3\-6'SF&U3,MY*5"M/<2MEYIF"J#)(68A
M0,X``])HHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*
M***`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`\_P#$OPO\4KXE
MUB^\,>+[71(M?:.2ZAO=);4#;R*B1-);GSXQ&S1(HPZR('4/MY=7Z[P7X0T[
MX>^#])T#1[5++2=$LX;"RMT)*P0Q($1`222`J@<DGBBBK<VURD1IQ3YEO_7W
M&E1114%A1110`4444`-$A.<#H,T"0G&0!GWHHJ[:$.3YK#J\1_:,_P"";7P&
M_:Z^*_ASQQ\3?A3X.\<>*/"L#VMA>:M8BX!@8L?)GC/[NYB5F=D2=9%1G=E"
MLS$E%06>QZ!H%AX4T2TTS2[&STW3;")8+:TM85A@MXU&%1$4!54`8````JW1
D10`4444`%%%%`!3/.XR1@9Q110`OF':&`!!QWYYIU%%`'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img123.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img123.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!%`*<#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MH=2U*WT?3[B\O+B&UM+2-IIIIG$<<**,L[,>%4`$DG@`5^:O[7?_``=9?LO?
MLXZIK.B>$;_7_C-XDTF%W\KPE:B73&94W'-\Y$31@<M+")549ZD$4`?IA2"0
M%RFX%E`)&>0#G!_0_E7@G_!,3]NNS_X*3_L1^"_C)9Z)'X9/BM;H3Z.NHC4#
MIDL%U+;M$TPCCW$^4&YC7AQQW/Y[?\&Y7_!0#4?^"@'_``48_;/\9:AJ-U=V
M>M7FD2^'X)9F9+/2;>6_@MHHT/"`1E&;:!EY'8\L20#]A:***`"BBB@!GVF/
M[08?,3S@N_9N&[;G&<=<9[TYI51U4L`S_=!/)^E?D?\`LK>);CXV_P#!W'\?
M]1%U<RZ=\./AC#H<2BX9HXW+:83'CH%WS7#;>@;)Z\U]6?ME_P#!+74/VO?^
M"B/P)^-UO\8O$GA"S^"$PGF\+Z=`636&\[SBIF$R^2LR@0S`QR>;"-GRYS0!
M]BT444`%%8GQ,^).A?!SX=Z[XM\4:G:Z+X<\-6$VIZG?W+;8K.VA0R22,>N%
M52>.>..:_+?PA_P<)_'/]H#P3XN^,GPC_9$UCQC^SAX'FNHKK7KSQ3#I^M:Q
M#!S-=VMH8V++$F2T:";)5E\Q6#J@!^L=%>>?LG?M/>%?VS_V<?"'Q2\$W%Q<
M^&/&E@M_9&XC$<\7S%'BD4$A9(Y%=&`)`9#@D<UZ'0`4444`%%%%`!7C?[<W
M[?7PM_X)S?!&?Q_\6/$D>@Z*)A:VD,<;7%[JERP)6"WA7YI'(!)QA54%F*J"
MP](^)GQ(T/X.?#G7O%OB;4K?2/#OAC3Y]4U.^G.(K2VAC:261O944GCGBOYI
MOVL_^"H-I_P4%_;RU3XT^/OB=XX_9B\&?"_PFUY\(;2T\,_VCXA\1VUU<M`U
M[9K-(D"7$S+EY$D4!(0BR$1/)0!W'_!:O_@Y'A_;A^!6A_##P-\*OB?X9\,:
M]XCM+O6AKY.FOXSTF/+'3%^SLSHMPYC+&-R<(`"=Q%;?[/?[7UW^T%_P1D_;
MLC_X4G\)?@9??#[1K/PU::3X2\,MHVHPI.)8[R&]DD8S32[(FW;\-GS-V<\7
M8OBA\3O$G[1&@?L4_MJ^-+GXN?![]HBPL=9^&?Q)M+4:=JVG7$QWZ9>Q2/&K
MI(9!Y,MO<+(\;RJ-S1.?,Y'_`()(_P#!'KPK\=/V\_VYOA]XZ\5^(O&'B_X;
M66I^%]#U&]D"2:I<:G%J=C+J\Z.7+W"+L*,68!KAF.X[2`#M?^#;K_@H'J7[
M`5[\2OV5/BE,-.U6YTM_'?@*8/YMM<O-I2W[6Z2?W9[;R+B(8`+></ONJGQ_
M_@TX\0:C^R;_`,%88?!'B@BW'QD^&8O-*2)]T<S2);ZG;.QZ`_9H[E<=F;%9
M_P"TY^Q8/^"B/_!"'X>_'[P];-'\7OV5[&3X<>/M-13YU[I>FRA(F(&3YUI;
MRP2DMMS$T^2?+C6N-_:4U?Q!^R%\%O\`@G!^UUX=@,B:%X7BT"YAC&Q9I=)U
M2ZE,4C8_Y>+>YGCR3G;&0,`4`?T^?M$_M!^$?V4O@AXF^(OCS6(=!\(^$;)K
M_4KV4%O+0$`*JJ"SR.Y5$106=W50"2!7XP?M"_\`!YV=#^'DNL>`/V>O$\5I
MJFH&W\/:YXINC%IFK10R@7/$*C]ZJ%!LCE?8T@W$@8;V+_@ZL^/-G\6?^"%O
MA_Q5X.U!;[PK\1?$&A7D=PC<75E+#+=Q9QD??2(D9X*^U>:_\'$/P@\,_#__
M`(-J_@9I&F06D%GX4G\*II)"*'D)TN:-V!P"7=7=V(Y8Y8YYH`^B?^#EKXJ_
MM)?!+]BO3/BK\#/B)8>`_"_@JXM]0\3I;Q_\3C4?.FBAMQ%(R-&8$:0%XR%W
MYY)"[3X=_P`$C/V1?VM/^"C=Y#^T?\?_`(^^)=.^&?Q9\*:KI0\#:)J-Q9>?
M8W5K)90SQP)BVLR,_:HY(PTA9(V)^=A7T!_P<^^-?^$:_P""%'CH1;%&N2:'
M8@#D;7O;=R!^"5[;\$I)O@O_`,$+O"\^CPS&[\.?`^WN+6.)3YAECT)77`'.
M2X_.@#\P?^#/;]A[PSXM^)GQ?_:%F/B&^N?#&NS>$/"EU=WYYB>+S;E[A4"B
M:;R9;49;Y`68A0VTJ[_@F/X`U_X5_P#!V5\:?"'A'QWXY\3>$-'T^_N_$5QK
M>K27T^HJUI:D17+G`D,-[<JD98;E6(#/7/:_\&<'[8/PXT+]C+QM\((=0O)?
MBI;>(=4\:W&@Q6D\LU_8"TT^`7$+[?*^\B1>67#[AG;A@3Y+_P`&E_[5.F_%
MK_@I?^TAKGCJ'5O^%L_%=/[7MO(T^:6UM8A=75QJ*32`$6X$C6:IYNT$@*#N
M(!`.J_X*7?M@_MG_`+.G_!?;3/A'\#/BSJOCJZ^(-K!J.C>$M8L+7^Q]+BN!
M<EK>2-$7]U;0PM,9\B78F79R"6^B_P#@E-_P4!_:I;_@L7\4?V5?V@_$G@;X
MB'PAX5/B%M8\/::EHFGR'[`\81E2+=$4O@CK)&7$@3#`!@W-_P#!'[6=+_;!
M_P""K7[9?[9NN^0WA7P3=OX'\)W87S%2SLXL7%RO0JQM;:V?N3]LD&0!S!_P
M:[:FG[2&J_M6_M>^(;9SXA^(_C6YL(XU`>2QL8(DO3;H!SC%S`G7G[.GIF@#
MZL_X.&OBKX&\,_\`!*WXN^$O%'Q"\,^"=<\9>'+B'0;?4M06"XUB>$K-]FAC
M&9)#)Y8C)52H\T;B`<UF?\$I?AMX>_:7_P"#?GX4>#O"6O:]X(TSQ)X!31[W
M5-$BB74+6ZRT6I/")8W7?)<+<C=L)Q)E<-@C\J/^"8D'AG]O?XM?M`_\%#/V
MN+:;Q?X.^&5W%;>'_#DD"WEO/>N5%M8PVS8240K+:00Q-\DDUT'<[@6/NWQ3
M_P""J?[<_P"TU^W3X<_9BM='\$?L4W'CJT:[\.76N:?)J.I7=HB.RP0W(66U
M,S1QLH58H=KQL@D60HC`'Z3?\$:_C5\#?B-^QEIGA/X"0>(=*\*?"FZE\*W6
MC>(;*6SUG2[J,^;)]JCDY\R4RF8L/E)D885E9%Q?^"J/_!<GX)_\$G]$BM/&
M.HW/B3Q]J$!N-.\(:*5DU"5.BRSL3LMH23P\AW,`VQ)-K`?)O[4?Q9\,?\&N
M7_!-;5-*T7Q5J7Q-_:'^,^L76HIK.N'S;K6=6DC19]4G1F9A;6ZB/"%G+RR(
M"3YDCK9_X(1_\$*;GP;J"?M0?M/Q3>.?CYX[F77[*UUU?M#>&/,_>)-*C<&^
M8%3R/]'`5$"LI(`&?"']O3_@IU^W[%'X@^&GP&^$?P5\!:BOG:=??$":[>\F
MC(!4[0ZRLK`@AQ9JI'1C7;_"_P#X+"_'?]C+]L7P3\%/VV?`/@CP[#\3IELO
M"/Q$\$SSOH%_=ET003I,2\?SRQHSGRS&71FC\I_-7I/CM^V!\2?V@/\`@N)I
MO[-/A[XE)\&?`7P[\,VWC/79H;:U.L^/9GDC86-K)<JZI;JDB;S&N_\`=W`.
M1M*?#G_!S+^W'X8_X*/_`+0'P3_93^!MW9?$#Q?9^,HKS4]3TC;=065ZZ&WB
MM(KA"5;8DLTMP1\D7EQ[F#)($`/W]HJ#2K1]/TNVMY)GN9((EC:5AAI2``6/
MN>M%`'Y7?\'A/[1&I_!O_@E1:^&=)N)()?B;XML]#OBC%&-C%#/>2#(ZYDMX
M%(/!5VKV?XH_#7]DKX,?LV_LJCX\^"_`=SI]E9:3X2\(ZUXBTN&>RT:9=,,T
M27%Q(-L<+_9L#S"4,K(2!DL/GK_@\Y^%MYXR_P""8?A+Q#:1-*OA#Q]9S7K9
M`$-M/:7EOO\`?]\]NN!_?]J^K/\`@FEKW@3_`(*F?\$;/A&?'F@:#X[T+7?"
MEII.O:=JMJEU!)?V(^RSN4;.R03P-(C##H2K*0<&@#XU_P""M7C#PE_P4E_X
M*_\`[&7PR^"VKZ'XV\6?"KQ$WC3Q1JVC31ZA8^&]*AN;*?;/+$WEAF-J?W>\
M-N>`'!E3=\5_M-V'[4__``1T_P""_P!HUYX6^(&C?%_XI_'RWL8OM^JZ'#H6
ME^+/MURMJ+&:W6?RX/+GMX0KQRJ1A#GYF4_LKXX\0_L<_P#!O)\%1J[:-X;^
M$FD^+[\6L:Z9I\]_JNNSHI;9N`DN)(XU).7;RX]_53(`WYM_\'('Q]\"_MC?
MLR_L^_MG?L]^+;/Q*GPB\9_V7=WMK'+;7FG3.T5W;"XBD"RPF*XM``&4$_:U
M9<JP8@'J'_!.+4M:_8<_X+M?%?\`9[^*.F^'X[/]K+PK!X[GT>Q1Y]&CUQ[6
M:?4K6W$@;=;.W]JH"Y7<D$2D$XKZC_:)_P""$7AWXG?\$88OV5K'7GU&\\%M
M<ZIX*UR^MQ&]C?K=7-Q:B0`M\OE7#VLCCDI([A02%'P#^W-^TQHW[6__``<D
M?L+^*_AO?PZC>:AX5\-ZA?"V<LUI!=S7E\T,FWD,+*X+LIZ+(,]Z_H"H`_EB
M_9A^+FN_'/\`8#^)W_!.7XSWL?P]^*/A?5TU'X8/XFD2SMDU."X,\NA7$SX2
M(S[IOLTKN$9KK`<CRD?Z"\+?\$;O^"@/_!47]G'P7\'/CYK7A_X2?#3X*Z8(
M?##7T5IJ%UKUU%%]GM5G6SG8LL4`:,7#%<(VX),SLP_67_@HU_P1%_9\_P""
MH=[::K\2?"]U:^*[&,01>)=!N1I^JM",8BDDVLDR#'RB9'V9.W;N.>N_X)[?
M\$P_AI_P32\&:EH_P^G\8ZC)K`A6]OO$6O3ZE<2I$&\I%5B(8E7>_$4:9W<Y
MP,`'`?!'_@CAX17_`()KZ#^SI\=/$?B7X[Z997$=_J%_K&K7UN\L\;AH8K<I
M/YL%O"JI&D0DVX4DCYB*^M/"O@W3/!/@W3?#VEV<5KHND646G6EH,M'#;QQB
M-(_FR2`B@<D\"M.B@#RK]FK]AKX/?L<W&O3?"WX;>$/`<WB:X^TZG)H^G1VS
MW;=E+`9$:G)6-<(I9BJC)SWGASX<^'O!VL:GJ.D:#HVE:AK4GG:A<V=E%!-?
M/DG=*ZJ#(V68Y8DY8^M;-%`&-IOPY\/Z+H&H:39Z%H]GIFK/+)>VD%E'%!>-
M*,2M(B@*Y<<,2"6[YKQ7]@O_`()??![_`()JZ)XOTSX2:'J>B:9XVU!=0U"T
MNM6N;^!&565$B69V"*JL1GEF&`S-M7'T&6P0">3T]Z*`/Q8\:_\`!'WXH?L.
M^&OBI\&O#7P:/[2W[)_Q5\1P>++71='\8Q>%_%'@J\BECE"+),RK<Q`0Q1@(
MVY@BL=AW!O<?AM^Q[\>?^"B'_!3+X5_'SXX?#JP^!7P^_9^M;I/"'@^77K?7
MM:UV]G4K]KN)[8^7#&`('V%F8-;A<,'9Q^FU%`'X5ZO\-5_X*@_\'=>O:/XR
M']H^"OV;M$@U&QTR8;X)C:):O&K+D#!U&_\`..0=RQ!&!7@?I9_P65_;'\=_
M\$^OV$]>^,O@2Q\,:Q-X%U+3[C6-,UI)=FI:?-=1VLL4,D;J8IMT\;*[!P`K
M?*Q(%?)7_!0[]BWXV?L&?\%.9/VV?V;?!$7Q4A\4:.-$^)'@.*3R+^]A"PJ;
MFTV@EBPMK8D(KR)+%OV2I(XC^6_V\_VC/VK?^#@^TL?A)X>^!_BS]G7X&Z/<
MQZQXX\1^,XIK=!#`#)YLS21P[XX=K.MO"'9W2-F*!<J`?HO\?/\`@G;^S7_P
M7S_9L^%WQ@\=^&;^WN=:\-6FIZ7K6G:B;+5-.M)X_/:RED`,<B1R2.")$8(W
MF%-N]MW#G_@GK\'O^".?[*OB3Q_^S!X$TF\\<2E=/N?&%_,VO7VFVSM^\?>S
M%8HP1&C;`D4>Y9I@R1.#^8W[.WPW^-'_``<)?$'3_@U\+O%7B+X6_L8?`K3[
M3PW;7+[E?4H+>-8XIKJ-&07>I7*J9C&Q$-LK?WB#-[1^RG\#;7_@B#_P<2?#
M/]G[X,_$SQ7XW\%?%70"/&7AW69TF?393!<S122>2J0^<@@29&\M9$BF=22L
MN6`/UI_X)C?'_P`>?M&_LZ2ZW\0+:W_M*VU)[.UU""`11:I$L$+R.I3$4WE7
M#SVYG@_<3&V+Q%D8,Q7T2JA%"@`!1@`#`%%`'C_[?_[(NE_MX_L:?$3X2:N\
M<$7C71Y;.VNI%++8W8Q):W&!R?*G2)\#J%([U^)__!K=^W/JG[!/[5OQ`_8P
M^-#3>&M2U37I&\/17Q$<-EK<:F.YM-[X^6[CCA>`CY79,+N:=<_T(U\,?\%;
M?^""'PF_X*N_9O$5_=7OP_\`BII<`@L/&&D0+)*Z+S''=P%E%RB'E3O21>BR
M`9!`/LGXA?"KPO\`%S16TWQ7X;T'Q/I[JR&UU;3XKV$AAAALD5A@C@\<U_/;
M'_P1XF^,'Q3_`."A_@?X+_%J7X7_`+/W@_4].-YI#Z/'J6FZU>VEK+J$]D97
M</;K8W(:,-&Q;:Z;MP4`_<WPA_X)F_\`!1'1]$@\">)?VW]'M_A];1BR_M73
M?"L-YXHEM`-I5;F>%9(YF7($S3R2(2&#-C!\H^.G_!+7]M+P)\1/&W[,_P``
M=2\+>%OV//B-8VEE/X@U1[*[U;3()K6*/6I)G(6\N;R\F:Z=RX=65T2.2W4!
M8P#9_P"#4K_@DE\.?A)^RIX-_:<U&VO=9^*?CRSO18RW@"VWANS^TSVQ6UC`
M_P!9-'$"\S$ML?8FQ2_F?L17%?LW?`;0OV6_@!X,^&_AE)4T#P/HUKHMCYIW
M2O%!$L8=SW=MNYCW9B:[6@#\C_\`@Z.\5ZYX.\9?LI)HFO?&33T\3^-YM!U7
M3/ASKD]CJ^N64IM2]O;Q*XCDNR?EA+CAG(SAN+_[<WP`_:4^!O\`P19O?#/[
M//Q"^-7C3Q=JNN6FK/8>);R"X^(?A_0I[6-[G1Q/;LS2W4%P\;,8R76.21%9
ME52WUK_P4J_X)&^"?^"H&N?#[4?&'C/XD^%;OX97,]]H;^%=4BT]H+J5H&-R
M6,+OYR?9TV.K#9EB,$DGCKK_`((-_"P?!3P!X2T[QK\7M#UGX?\`BB^\8V_C
M73_$8B\5:CJ=[$T5S/<7IB)<R#R@V%&5@13D9R`?#O\`P1Q^%_@C]K?P9^U#
M\+O#_P`;?VLO!FI:I'HDGB+PYXUEAL_&_AMK8SFX,.H8D62&XW+`W[B&9!$`
MRX=2>M_X-3/@3XS\?_!.3XZZW\:_BUKKRZQJ_A>]\+:YK+ZGHUY;Q>0;>=$E
MR\,\;ER7!.X,5PH)S^@W[''_``3)\"_L<^(?'OB:VUGQIX[^(7Q0\I?%/C#Q
M5JGVS5]4CAC,<,.Y%CCBCC0X41HIP%!)"(%W_P!@O_@G]\/?^"<7[/[?#3X;
MQ:RGAJ34;G5'&IW[7=PTT^T.=^!@810``.F>222`>QZ-KUCXCLC<Z?>VM_;B
M1XO-MYEE3>C%'7*DC*L"I'4$$'D5^9_Q%\=>,M&_X.J?A[X9N_&NO7W@O4_A
M1>ZE8>'I)REAILS>;'-Y<:X5F<VJ2%WW-GC(55`^R?\`@GY_P3R^''_!,WX&
MW7P\^%]MK-MX>O=8N=<F&IZ@][,UQ.(T;#-@*BQQ1(JJ`,)D[G9F:+Q/_P`$
M[_`/B_\`;^\._M)7T_B5_B'X6T!_#>GQKJ&S3(K5_/W9@"Y9S]HDY+$?=X^4
M4`?A'_P51GMOCA^V+^W/XMOO@_\`$']HS3?AVMII/AWQS8Z]>:;I_P`'KNWM
M<7<:01G9,(;A0\F%./LS,P597<_ID?A9X`_;=_X)5?LF^%/B_P#%>_\`&!\6
MZ=IM_!I1UU]&;XLZA'H\[C3+F9<3F(2,&<YR7@0OERM>D?M(_P#!!7X+_M(?
M%GQCXIEUSXJ>"[;XF2QS^.?#WA/Q9/I>A^-)4QB2^M@&5F./F*%-Q+,?G9F/
MIO[2_P#P2N^#7[4/[./@OX8:KH5_X=T+X:/;2^#;SPWJ$NF:GX4DMXO)B>TN
M4)92(^"'WJQ"LP+JK``_-;_@BG>ZC\#==_;M_9RU_P`4:M^S=J'AJR&O>'?#
M]WX@&OQ?"[3)K*5I=1M[]W\N58EN;*1B67&(V)W%RO/?`#P/;_\`!*'_`(+6
M?LXZ?X=N_'FB?!?XS^'Y]!OO&-_XG3Q#I?QEUB6W,D.J>4D\WV,R7$]FRN",
M@IA$1Y9&_1;]C7_@B#\#OV-?#'Q,M+:V\3^/M6^,5C+I7C'7/&&K/J6IZU92
MHZR6S2@)MC<.Q8J`[G:69MB;>%_9(_X-Z?A7^RW^T-X5^(%_XW^*GQ-/PS26
M'X>Z)XOUO[=I?@>)RV%M(@HR44@)N^52JL%WHC*`??->;_MB_!&[_:7_`&2O
MB=\.K&]BTV^\=>%=2T"VNY21';275K)"CM@$[0S@G`)P#@&O2**`/YP/V,/^
M"A_[3O\`P13_`&2=:_9=TO\`9+\67WQ>CU^^N-*UZ/3;N\T_4#.%'V@101,+
MUDV!4>*4(R+&#C80WW#_`,&^_P#P1D^('[//Q&\3?M/_`+2E]=:M\??B(LQ@
ML[NX6XGT.WN"K32W#*-@NY=H7RXR5AA`3.79(_T^^+/AS6_&/PK\3:1X;U]O
M"OB/5=*NK/2M:%JMV='NI(62&Z\ER%E\J0J^QB`VW!X-<M^R!\*O&OP0_9K\
M(^%/B+X^N/BAXTT6S,.J>)Y[);.359#([*QC4D#8C+'N)+.(PS?,QH`])HHH
MH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@
##__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
